Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery?Zacks Investment Research • 01/29/26
Curious about Revvity (RVTY) Q4 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 01/28/26
Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 01/23/26
Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio ActivitySeeking Alpha • 01/21/26
Revvity, Inc. (RVTY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial PerformanceBusiness Wire • 01/12/26
RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery ModelsZacks Investment Research • 01/12/26
Revvity Advances AI-Driven Scientific Discovery With Signals XyntheticaZacks Investment Research • 12/19/25
Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials DiscoveryBusiness Wire • 12/16/25
Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 TranscriptSeeking Alpha • 12/02/25
Revvity (RVTY) Up 9.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/26/25
Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/18/25
Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/10/25
Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay AccuracyBusiness Wire • 11/10/25